{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T21:34:01Z","timestamp":1781991241265,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MSH 217672"],"award-info":[{"award-number":["MSH 217672"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-154320"],"award-info":[{"award-number":["FDN-154320"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Health Research BC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005247","name":"University of British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.josat.2023.209134","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T13:39:02Z","timestamp":1691674742000},"page":"209134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["\u201cI thought it was for guys that did needles\u201d: Medication perceptions and lay expertise among medical research participants"],"prefix":"10.1016","volume":"154","author":[{"given":"Kaitlyn","family":"Jaffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.josat.2023.209134_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0208410","article-title":"Establishing trust in HIV\/HCV research among people who inject drugs (PWID): Insights from empirical research","volume":"13","author":"Abadie","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.josat.2023.209134_bb0010","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/08897077.2019.1640833","article-title":"Underutilization of medications to treat opioid use disorder: What role does stigma play?","volume":"40","author":"Allen","year":"2019","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.josat.2023.209134_bb0015","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/1467-9566.ep11347516","article-title":"Expert and lay participation in the construction of medical knowledge","volume":"16","author":"Arksey","year":"1994","journal-title":"Sociology of Health & Illness"},{"issue":"1","key":"10.1016\/j.josat.2023.209134_bb0020","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/inm.12523","article-title":"Readiness and recovery: Transferring between methadone and buprenorphine\/naloxone for the treatment of opioid use disorder","volume":"28","author":"Bishop","year":"2019","journal-title":"International Journal of Mental Health Nursing"},{"key":"10.1016\/j.josat.2023.209134_bb0025","series-title":"Estimating the size of the fentanyl market in British Columbia","author":"Bouchard","year":"2020"},{"issue":"5","key":"10.1016\/j.josat.2023.209134_bb0030","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/dar.13113","article-title":"Use of a novel prescribing approach for the treatment of opioid use disorder: Buprenorphine\/naloxone micro-dosing \u2013 A case series","volume":"39","author":"Brar","year":"2020","journal-title":"Drug and Alcohol Review"},{"issue":"January","key":"10.1016\/j.josat.2023.209134_bb0035","article-title":"A good \u201cdoctor\u201d is hard to find: Assessing uncredentialed expertise in assisted injection","volume":"237","author":"Brothers","year":"2019","journal-title":"Social Science and Medicine"},{"issue":"9","key":"10.1016\/j.josat.2023.209134_bb0040","doi-asserted-by":"crossref","first-page":"E247","DOI":"10.1503\/cmaj.170958","article-title":"Management of opioid use disorders: A national clinical practice guideline","volume":"190","author":"Bruneau","year":"2018","journal-title":"Canadian Medical Association Journal"},{"issue":"5","key":"10.1016\/j.josat.2023.209134_bb0045","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1046\/j.0269-4727.2003.00511.x","article-title":"Negotiating medications: Patient perceptions of long-term medication use","volume":"28","author":"Carder","year":"2003","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"4","key":"10.1016\/j.josat.2023.209134_bb0050","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Current Opinion in Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2023.209134_bb0055","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1177\/136345930100500403","article-title":"Medications as social phenomena","volume":"5","author":"Cohen","year":"2001","journal-title":"Health"},{"key":"10.1016\/j.josat.2023.209134_bb0060","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jsat.2018.10.009","article-title":"Health literacy in substance use disorder treatment: A latent profile analysis","volume":"96","author":"Degan","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"7","key":"10.1016\/j.josat.2023.209134_bb0065","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1360-0443.2007.01862.x","article-title":"Enhancing the validity and utility of randomized clinical trials in addictions treatment research: I. Treatment implementation and research design","volume":"102","author":"Del Boca","year":"2007","journal-title":"Addiction"},{"key":"10.1016\/j.josat.2023.209134_bb0070","series-title":"Dissemination","author":"Derrida","year":"1981"},{"key":"10.1016\/j.josat.2023.209134_bb0075","article-title":"Flexible coding of in-depth interviews: A twenty-first-century approach","author":"Deterding","year":"2018","journal-title":"Sociological Methods and Research"},{"issue":"2","key":"10.1016\/j.josat.2023.209134_bb0080","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1080\/08897077.2019.1572052","article-title":"Demystifying buprenorphine misuse: Has fear of diversion gotten in the way of addressing the opioid crisis?","volume":"40","author":"Doernberg","year":"2019","journal-title":"Substance Abuse"},{"issue":"Suppl. 1","key":"10.1016\/j.josat.2023.209134_bb0085","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/QAI.0b013e3182097561","article-title":"Patient perspectives on buprenorphine\/naloxone treatment in the context of HIV care","volume":"56","author":"Egan","year":"2011","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"issue":"4","key":"10.1016\/j.josat.2023.209134_bb0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1177\/016224399502000402","article-title":"The construction of lay expertise: AIDS activism and the forging of credibility in the reform of clinical trials","volume":"20","author":"Epstein","year":"1995","journal-title":"Science, Technology, & Human Values"},{"issue":"March","key":"10.1016\/j.josat.2023.209134_bb0095","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.socscimed.2019.04.004","article-title":"Unravelling subjectivity, embodied experience and (taking) psychotropic medication","volume":"230","author":"Flore","year":"2019","journal-title":"Social Science and Medicine"},{"issue":"5","key":"10.1016\/j.josat.2023.209134_bb0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJMra1510059","article-title":"Pragmatic trials","volume":"375","author":"Ford","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209134_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12889-018-5765-2","article-title":"Participant, peer and PEEP: Considerations and strategies for involving people who have used illicit substances as assistants and advisors in research","volume":"18","author":"Greer","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/j.josat.2023.209134_bb0110","series-title":"Critical perspectives on addiction","first-page":"79","article-title":"Two tiers of biomedicalization: Methadone, buprenorphine, and the racial politics of addiction treatment","volume":"Vol. 14, Issue 12","author":"Hansen","year":"2012"},{"issue":"6","key":"10.1016\/j.josat.2023.209134_bb0115","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/1049732311432718","article-title":"Methadone as social control: Institutionalized stigma and the prospect of recovery","volume":"22","author":"Harris","year":"2012","journal-title":"Qualitative Health Research"},{"key":"10.1016\/j.josat.2023.209134_bb0120","first-page":"1","article-title":"Introduction: Illegal drug markets, research and policy","volume":"11","author":"Hough","year":"2000","journal-title":"Crime Prevention Studies"},{"key":"10.1016\/j.josat.2023.209134_bb0125","article-title":"Flexible buprenorphine\/naloxone model of care for reducing opioid use in individuals with prescription-type opioid use disorder: An open-label, pragmatic, noninferiority randomized controlled trial","volume":"1\u201314","author":"Jutras-Aswad","year":"2022","journal-title":"American Journal of Psychiatry"},{"issue":"6","key":"10.1016\/j.josat.2023.209134_bb0130","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/1545109708328130","article-title":"Association between health literacy and HIV treatment adherence: Further evidence from objectively measured medication adherence","volume":"7","author":"Kalichman","year":"2008","journal-title":"Journal of the International Association of Physicians in AIDS Care"},{"issue":"9","key":"10.1016\/j.josat.2023.209134_bb0135","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1001\/jama.293.9.1089","article-title":"Impact of participant and physician intervention preferences on randomized trials: A systematic review","volume":"293","author":"King","year":"2005","journal-title":"JAMA"},{"issue":"02","key":"10.1016\/j.josat.2023.209134_bb0140","doi-asserted-by":"crossref","DOI":"10.4172\/2324-9005.1000106","article-title":"Substance use related stigma: What we know and the way forward","volume":"02","author":"Kulesza","year":"2013","journal-title":"Journal of Addictive Behaviors Therapy & Rehabilitation"},{"key":"10.1016\/j.josat.2023.209134_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.drugalcdep.2016.10.020","article-title":"Towards greater understanding of addiction stigma: Intersectionality with race\/ethnicity and gender","volume":"169","author":"Kulesza","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209134_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108338","article-title":"Health communication campaigns to drive demand for evidence-based practices and reduce stigma in the HEALing communities study","volume":"217","author":"Lefebvre","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.josat.2023.209134_bb0155","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1146\/annurev.soc.27.1.363","article-title":"Conceptualizing stigma","volume":"27","author":"Link","year":"2001","journal-title":"Annual Review of Sociology"},{"key":"10.1016\/j.josat.2023.209134_bb0160","series-title":"Handbook of the sociology of mental health","first-page":"525","article-title":"Labeling and stigma","volume":"Second","author":"Link","year":"2013"},{"key":"10.1016\/j.josat.2023.209134_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.103014","article-title":"Making legitimacy: Drug user representation in United Nations drug policy settings","volume":"87","author":"Madden","year":"2021","journal-title":"International Journal of Drug Policy"},{"issue":"January","key":"10.1016\/j.josat.2023.209134_bb0170","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.socscimed.2019.05.027","article-title":"Intervention stigma: How medication-assisted treatment marginalizes patients and providers","volume":"232","author":"Madden","year":"2019","journal-title":"Social Science and Medicine"},{"issue":"7","key":"10.1016\/j.josat.2023.209134_bb0175","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1177\/1049732313487802","article-title":"A metaphor analysis of recovering substance abusers\u2019 sensemaking of medication-assisted treatment","volume":"23","author":"Malvini Redden","year":"2013","journal-title":"Qualitative Health Research"},{"issue":"1","key":"10.1016\/j.josat.2023.209134_bb0180","doi-asserted-by":"crossref","DOI":"10.18584\/iipj.2015.6.1.7","article-title":"Canadian drug policy and the reproduction of indigenous inequities","volume":"6","author":"Marshall","year":"2015","journal-title":"International Indigenous Policy Journal"},{"issue":"2019","key":"10.1016\/j.josat.2023.209134_bb0185","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugpo.2019.10.005","article-title":"Ambiguous identities of drugs and people: A scoping review of opioid-related stigma","volume":"74","author":"McCradden","year":"2019","journal-title":"International Journal of Drug Policy"},{"issue":"2","key":"10.1016\/j.josat.2023.209134_bb0190","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1080\/10826084.2017.1342662","article-title":"Medication-assisted treatment for opioid addiction in the United States: Critique and commentary","volume":"53","author":"McElrath","year":"2018","journal-title":"Substance Use and Misuse"},{"issue":"4","key":"10.1016\/j.josat.2023.209134_bb0195","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/0277-9536(88)90310-3","article-title":"The metaphorical nature of drugs and drug taking","volume":"26","author":"Montagne","year":"1988","journal-title":"Social Science and Medicine"},{"issue":"6","key":"10.1016\/j.josat.2023.209134_bb0200","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/add.14163","article-title":"Improving recruitment to pharmacological trials for illicit opioid use: Findings from a qualitative focus group study","volume":"113","author":"Neale","year":"2018","journal-title":"Addiction"},{"issue":"8\u20139","key":"10.1016\/j.josat.2023.209134_bb0205","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3109\/10826084.2012.663292","article-title":"The science and practice of medication-assisted treatments for opioid dependence","volume":"47","author":"Pecoraro","year":"2012","journal-title":"Substance Use and Misuse"},{"issue":"1","key":"10.1016\/j.josat.2023.209134_bb0210","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1146\/annurev-soc-071312-145702","article-title":"The stigma complex","volume":"41","author":"Pescosolido","year":"2015","journal-title":"Annual Review of Sociology"},{"issue":"1","key":"10.1016\/j.josat.2023.209134_bb0215","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.socscimed.2004.11.063","article-title":"Resisting medicines: A synthesis of qualitative studies of medicine taking","volume":"61","author":"Pound","year":"2005","journal-title":"Social Science and Medicine"},{"issue":"SPEC. ISS","key":"10.1016\/j.josat.2023.209134_bb0220","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1467-9566.00339","article-title":"Belief, knowledge and expertise: The emergence of the lay expert in medical sociology","volume":"25","author":"Prior","year":"2003","journal-title":"Sociology of Health and Illness"},{"key":"10.1016\/j.josat.2023.209134_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2020.102840","article-title":"Ranking evidence in substance use and addiction","volume":"83","author":"Reddon","year":"2020","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2023.209134_bb0230","doi-asserted-by":"crossref","DOI":"10.1177\/16094069221131168","article-title":"Research participation in substance use disorder trials: Design and methods of a multi-site nested qualitative study","volume":"21","author":"Richardson","year":"2022","journal-title":"International Journal of Qualitative Methods"},{"issue":"3","key":"10.1016\/j.josat.2023.209134_bb0235","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jsat.2011.12.008","article-title":"Addiction treatment-related employment barriers: The impact of methadone maintenance","volume":"43","author":"Richardson","year":"2012","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"12","key":"10.1016\/j.josat.2023.209134_bb0240","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/S0895-4356(99)00141-9","article-title":"Barriers to participation in randomised controlled trials: A systematic review","volume":"52","author":"Ross","year":"1999","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1016\/j.josat.2023.209134_bb0245","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1207\/S15327957PSPR0504_2","article-title":"Negativity bias, negativity dominance, and contagion","volume":"5","author":"Rozin","year":"2001","journal-title":"Personality and Social Psychology Review"},{"key":"10.1016\/j.josat.2023.209134_bb0250","doi-asserted-by":"crossref","DOI":"10.1177\/1049732320938689","article-title":"Overcoming barriers: Individual experiences obtaining medication-assisted treatment for opioid use disorder","author":"Scorsone","year":"2020","journal-title":"Qualitative Health Research"},{"issue":"2","key":"10.1016\/j.josat.2023.209134_bb0255","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/135910539900400217","article-title":"Symptom interpretation and medication adherence among late middle-age and older HIV-infected adults","volume":"4","author":"Siegel","year":"1999","journal-title":"Journal of Health Psychology"},{"issue":"April","key":"10.1016\/j.josat.2023.209134_bb0260","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cct.2018.04.001","article-title":"The OPTIMA study, buprenorphine\/naloxone and methadone models of care for the treatment of prescription opioid use disorder: Study design and rationale","volume":"69","author":"Socias","year":"2018","journal-title":"Contemporary Clinical Trials"},{"issue":"4","key":"10.1016\/j.josat.2023.209134_bb0265","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/add.14080","article-title":"Toxicity: Exploring and expanding the concept","volume":"113","author":"Strang","year":"2018","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209134_bb0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0735275112457914","article-title":"Theory construction in qualitative research: From grounded theory to abductive analysis","volume":"30","author":"Timmermans","year":"2012","journal-title":"Sociological Theory"},{"key":"10.1016\/j.josat.2023.209134_bb0275","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103788","article-title":"Can a new formulation of opiate agonist treatment alter stigma?: Place, time and things in the experience of extended-release buprenorphine depot","volume":"107","author":"Treloar","year":"2022","journal-title":"International Journal of Drug Policy"},{"issue":"11","key":"10.1016\/j.josat.2023.209134_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002969","article-title":"Stigma as a fundamental hindrance to the United States opioid overdose crisis response","volume":"16","author":"Tsai","year":"2019","journal-title":"PLoS Medicine"},{"key":"10.1016\/j.josat.2023.209134_bb0285","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.socscimed.2017.10.020","article-title":"The dark side of social capital: A systematic review of the negative health effects of social capital","volume":"194","author":"Villalonga-Olives","year":"2017","journal-title":"Social Science & Medicine"},{"issue":"2","key":"10.1016\/j.josat.2023.209134_bb0290","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/09505430902885631","article-title":"Making sense of medicines: \u2018Lay pharmacology\u2019 and narratives of safety and efficacy","volume":"18","author":"Webster","year":"2009","journal-title":"Science as Culture"},{"issue":"2","key":"10.1016\/j.josat.2023.209134_bb0295","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1353\/nib.2020.0044","article-title":"\u201cDeserving patients\u201d or \u201cpotential addicts?\u201d: Narrative analysis of an FDA hearing on prescription opioid labeling","volume":"10","author":"Wilbers","year":"2020","journal-title":"Narrative Inquiry in Bioethics"},{"key":"10.1016\/j.josat.2023.209134_bb0300","article-title":"\u201cDon\u2019t judge a book by its cover\u201d: A qualitative study of methadone patients\u2019 experiences of stigma","volume":"11","author":"Woo","year":"2017","journal-title":"Substance Abuse: Research and Treatment"},{"key":"10.1016\/j.josat.2023.209134_bb0305","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jsat.2019.03.010","article-title":"Willingness to participate in hepatitis C vaccine trials among socially marginalized people who use drugs","volume":"101","author":"Yakovenko","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2023.209134_bb0310","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.drugalcdep.2015.12.031","article-title":"Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis","volume":"160","author":"Yarborough","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"10.1016\/j.josat.2023.209134_bb0315","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1177\/1060028014526562","article-title":"Impact of health literacy on medication adherence","volume":"48","author":"Zhang","year":"2014","journal-title":"Annals of Pharmacotherapy"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923001856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:36Z","timestamp":1762652376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923001856"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":63,"alternative-id":["S2949875923001856"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209134","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cI thought it was for guys that did needles\u201d: Medication perceptions and lay expertise among medical research participants","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209134","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"209134"}}